nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Body temperature increased—Cimetidine—obesity	0.00218	0.00218	CcSEcCtD
Tobramycin—Epistaxis—Sibutramine—obesity	0.00218	0.00218	CcSEcCtD
Tobramycin—Bronchitis—Bupropion—obesity	0.00218	0.00218	CcSEcCtD
Tobramycin—Sinusitis—Sibutramine—obesity	0.00217	0.00217	CcSEcCtD
Tobramycin—Pharyngitis—Orlistat—obesity	0.00213	0.00213	CcSEcCtD
Tobramycin—Dry eye—Topiramate—obesity	0.00212	0.00212	CcSEcCtD
Tobramycin—Vomiting—Phentermine—obesity	0.00212	0.00212	CcSEcCtD
Tobramycin—Urinary tract disorder—Orlistat—obesity	0.00212	0.00212	CcSEcCtD
Tobramycin—Urethral disorder—Orlistat—obesity	0.0021	0.0021	CcSEcCtD
Tobramycin—Rash—Phentermine—obesity	0.0021	0.0021	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Bupropion—obesity	0.0021	0.0021	CcSEcCtD
Tobramycin—Dermatitis—Phentermine—obesity	0.0021	0.0021	CcSEcCtD
Tobramycin—Headache—Phentermine—obesity	0.00209	0.00209	CcSEcCtD
Tobramycin—Rash maculo-papular—Topiramate—obesity	0.00209	0.00209	CcSEcCtD
Tobramycin—Rhinitis—Sibutramine—obesity	0.00208	0.00208	CcSEcCtD
Tobramycin—Nausea—Phenylpropanolamine—obesity	0.00207	0.00207	CcSEcCtD
Tobramycin—Pharyngitis—Sibutramine—obesity	0.00206	0.00206	CcSEcCtD
Tobramycin—Weight decreased—Bupropion—obesity	0.00205	0.00205	CcSEcCtD
Tobramycin—Hypersensitivity—Cimetidine—obesity	0.00203	0.00203	CcSEcCtD
Tobramycin—Infestation NOS—Bupropion—obesity	0.00202	0.00202	CcSEcCtD
Tobramycin—Infestation—Bupropion—obesity	0.00202	0.00202	CcSEcCtD
Tobramycin—Visual impairment—Sibutramine—obesity	0.002	0.002	CcSEcCtD
Tobramycin—Diarrhoea—Diethylpropion—obesity	0.00199	0.00199	CcSEcCtD
Tobramycin—Nausea—Phentermine—obesity	0.00198	0.00198	CcSEcCtD
Tobramycin—Asthenia—Cimetidine—obesity	0.00198	0.00198	CcSEcCtD
Tobramycin—Neuropathy peripheral—Bupropion—obesity	0.00198	0.00198	CcSEcCtD
Tobramycin—Stomatitis—Bupropion—obesity	0.00197	0.00197	CcSEcCtD
Tobramycin—Ear pain—Topiramate—obesity	0.00195	0.00195	CcSEcCtD
Tobramycin—Eye disorder—Sibutramine—obesity	0.00194	0.00194	CcSEcCtD
Tobramycin—Immune system disorder—Orlistat—obesity	0.00194	0.00194	CcSEcCtD
Tobramycin—Tinnitus—Sibutramine—obesity	0.00194	0.00194	CcSEcCtD
Tobramycin—Mediastinal disorder—Orlistat—obesity	0.00193	0.00193	CcSEcCtD
Tobramycin—Dizziness—Diethylpropion—obesity	0.00192	0.00192	CcSEcCtD
Tobramycin—Blood alkaline phosphatase increased—Topiramate—obesity	0.00192	0.00192	CcSEcCtD
Tobramycin—Epistaxis—Bupropion—obesity	0.0019	0.0019	CcSEcCtD
Tobramycin—Sinusitis—Bupropion—obesity	0.00189	0.00189	CcSEcCtD
Tobramycin—Diarrhoea—Cimetidine—obesity	0.00189	0.00189	CcSEcCtD
Tobramycin—Angiopathy—Sibutramine—obesity	0.00188	0.00188	CcSEcCtD
Tobramycin—Immune system disorder—Sibutramine—obesity	0.00188	0.00188	CcSEcCtD
Tobramycin—Deafness—Topiramate—obesity	0.00186	0.00186	CcSEcCtD
Tobramycin—Disorientation—Topiramate—obesity	0.00186	0.00186	CcSEcCtD
Tobramycin—Eye pain—Topiramate—obesity	0.00185	0.00185	CcSEcCtD
Tobramycin—Vomiting—Diethylpropion—obesity	0.00185	0.00185	CcSEcCtD
Tobramycin—Nasal congestion—Topiramate—obesity	0.00183	0.00183	CcSEcCtD
Tobramycin—Rash—Diethylpropion—obesity	0.00183	0.00183	CcSEcCtD
Tobramycin—Dysgeusia—Orlistat—obesity	0.00183	0.00183	CcSEcCtD
Tobramycin—Dermatitis—Diethylpropion—obesity	0.00183	0.00183	CcSEcCtD
Tobramycin—Dizziness—Cimetidine—obesity	0.00183	0.00183	CcSEcCtD
Tobramycin—Headache—Diethylpropion—obesity	0.00182	0.00182	CcSEcCtD
Tobramycin—Rhinitis—Bupropion—obesity	0.00181	0.00181	CcSEcCtD
Tobramycin—Back pain—Orlistat—obesity	0.00181	0.00181	CcSEcCtD
Tobramycin—Pharyngitis—Bupropion—obesity	0.0018	0.0018	CcSEcCtD
Tobramycin—Urinary tract disorder—Bupropion—obesity	0.00179	0.00179	CcSEcCtD
Tobramycin—Connective tissue disorder—Bupropion—obesity	0.00178	0.00178	CcSEcCtD
Tobramycin—Urethral disorder—Bupropion—obesity	0.00177	0.00177	CcSEcCtD
Tobramycin—Dysgeusia—Sibutramine—obesity	0.00177	0.00177	CcSEcCtD
Tobramycin—Vision blurred—Orlistat—obesity	0.00176	0.00176	CcSEcCtD
Tobramycin—Vomiting—Cimetidine—obesity	0.00176	0.00176	CcSEcCtD
Tobramycin—Back pain—Sibutramine—obesity	0.00175	0.00175	CcSEcCtD
Tobramycin—Visual impairment—Bupropion—obesity	0.00174	0.00174	CcSEcCtD
Tobramycin—Rash—Cimetidine—obesity	0.00174	0.00174	CcSEcCtD
Tobramycin—Dermatitis—Cimetidine—obesity	0.00174	0.00174	CcSEcCtD
Tobramycin—Ill-defined disorder—Orlistat—obesity	0.00173	0.00173	CcSEcCtD
Tobramycin—Headache—Cimetidine—obesity	0.00173	0.00173	CcSEcCtD
Tobramycin—Nausea—Diethylpropion—obesity	0.00172	0.00172	CcSEcCtD
Tobramycin—Angioedema—Orlistat—obesity	0.00171	0.00171	CcSEcCtD
Tobramycin—Vision blurred—Sibutramine—obesity	0.0017	0.0017	CcSEcCtD
Tobramycin—Lethargy—Topiramate—obesity	0.0017	0.0017	CcSEcCtD
Tobramycin—Eye disorder—Bupropion—obesity	0.00169	0.00169	CcSEcCtD
Tobramycin—Tinnitus—Bupropion—obesity	0.00169	0.00169	CcSEcCtD
Tobramycin—Malaise—Orlistat—obesity	0.00168	0.00168	CcSEcCtD
Tobramycin—Vertigo—Orlistat—obesity	0.00168	0.00168	CcSEcCtD
Tobramycin—Ill-defined disorder—Sibutramine—obesity	0.00168	0.00168	CcSEcCtD
Tobramycin—Anaemia—Sibutramine—obesity	0.00167	0.00167	CcSEcCtD
Tobramycin—Angioedema—Sibutramine—obesity	0.00165	0.00165	CcSEcCtD
Tobramycin—Angiopathy—Bupropion—obesity	0.00164	0.00164	CcSEcCtD
Tobramycin—Nausea—Cimetidine—obesity	0.00164	0.00164	CcSEcCtD
Tobramycin—Immune system disorder—Bupropion—obesity	0.00164	0.00164	CcSEcCtD
Tobramycin—Mediastinal disorder—Bupropion—obesity	0.00163	0.00163	CcSEcCtD
Tobramycin—Malaise—Sibutramine—obesity	0.00163	0.00163	CcSEcCtD
Tobramycin—Cough—Orlistat—obesity	0.00163	0.00163	CcSEcCtD
Tobramycin—Vertigo—Sibutramine—obesity	0.00162	0.00162	CcSEcCtD
Tobramycin—Leukopenia—Sibutramine—obesity	0.00162	0.00162	CcSEcCtD
Tobramycin—Chest pain—Orlistat—obesity	0.00159	0.00159	CcSEcCtD
Tobramycin—Myalgia—Orlistat—obesity	0.00159	0.00159	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00158	0.00158	CcSEcCtD
Tobramycin—Cough—Sibutramine—obesity	0.00158	0.00158	CcSEcCtD
Tobramycin—Discomfort—Orlistat—obesity	0.00157	0.00157	CcSEcCtD
Tobramycin—Blood creatinine increased—Topiramate—obesity	0.00156	0.00156	CcSEcCtD
Tobramycin—Dehydration—Topiramate—obesity	0.00155	0.00155	CcSEcCtD
Tobramycin—Dysgeusia—Bupropion—obesity	0.00154	0.00154	CcSEcCtD
Tobramycin—Myalgia—Sibutramine—obesity	0.00154	0.00154	CcSEcCtD
Tobramycin—Chest pain—Sibutramine—obesity	0.00154	0.00154	CcSEcCtD
Tobramycin—Anaphylactic shock—Orlistat—obesity	0.00152	0.00152	CcSEcCtD
Tobramycin—Back pain—Bupropion—obesity	0.00152	0.00152	CcSEcCtD
Tobramycin—Discomfort—Sibutramine—obesity	0.00152	0.00152	CcSEcCtD
Tobramycin—Hypokalaemia—Topiramate—obesity	0.00152	0.00152	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Topiramate—obesity	0.0015	0.0015	CcSEcCtD
Tobramycin—Nervous system disorder—Orlistat—obesity	0.0015	0.0015	CcSEcCtD
Tobramycin—Confusional state—Sibutramine—obesity	0.00149	0.00149	CcSEcCtD
Tobramycin—Vision blurred—Bupropion—obesity	0.00149	0.00149	CcSEcCtD
Tobramycin—Skin disorder—Orlistat—obesity	0.00148	0.00148	CcSEcCtD
Tobramycin—Anaphylactic shock—Sibutramine—obesity	0.00148	0.00148	CcSEcCtD
Tobramycin—Muscular weakness—Topiramate—obesity	0.00147	0.00147	CcSEcCtD
Tobramycin—Ill-defined disorder—Bupropion—obesity	0.00146	0.00146	CcSEcCtD
Tobramycin—Anaemia—Bupropion—obesity	0.00146	0.00146	CcSEcCtD
Tobramycin—Thrombocytopenia—Sibutramine—obesity	0.00144	0.00144	CcSEcCtD
Tobramycin—Asthma—Topiramate—obesity	0.00144	0.00144	CcSEcCtD
Tobramycin—Angioedema—Bupropion—obesity	0.00144	0.00144	CcSEcCtD
Tobramycin—Skin disorder—Sibutramine—obesity	0.00143	0.00143	CcSEcCtD
Tobramycin—Eosinophilia—Topiramate—obesity	0.00143	0.00143	CcSEcCtD
Tobramycin—Malaise—Bupropion—obesity	0.00142	0.00142	CcSEcCtD
Tobramycin—Vertigo—Bupropion—obesity	0.00142	0.00142	CcSEcCtD
Tobramycin—Leukopenia—Bupropion—obesity	0.00141	0.00141	CcSEcCtD
Tobramycin—Anorexia—Sibutramine—obesity	0.00141	0.00141	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Orlistat—obesity	0.00139	0.00139	CcSEcCtD
Tobramycin—Bronchitis—Topiramate—obesity	0.00139	0.00139	CcSEcCtD
Tobramycin—Cough—Bupropion—obesity	0.00138	0.00138	CcSEcCtD
Tobramycin—Paraesthesia—Orlistat—obesity	0.00137	0.00137	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Sibutramine—obesity	0.00134	0.00134	CcSEcCtD
Tobramycin—Chest pain—Bupropion—obesity	0.00134	0.00134	CcSEcCtD
Tobramycin—Myalgia—Bupropion—obesity	0.00134	0.00134	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Topiramate—obesity	0.00134	0.00134	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00133	0.00133	CcSEcCtD
Tobramycin—Discomfort—Bupropion—obesity	0.00133	0.00133	CcSEcCtD
Tobramycin—Decreased appetite—Orlistat—obesity	0.00133	0.00133	CcSEcCtD
Tobramycin—Paraesthesia—Sibutramine—obesity	0.00132	0.00132	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Orlistat—obesity	0.00132	0.00132	CcSEcCtD
Tobramycin—Dyspnoea—Sibutramine—obesity	0.00132	0.00132	CcSEcCtD
Tobramycin—Weight decreased—Topiramate—obesity	0.0013	0.0013	CcSEcCtD
Tobramycin—Pain—Orlistat—obesity	0.0013	0.0013	CcSEcCtD
Tobramycin—Confusional state—Bupropion—obesity	0.0013	0.0013	CcSEcCtD
Tobramycin—Anaphylactic shock—Bupropion—obesity	0.00129	0.00129	CcSEcCtD
Tobramycin—Infestation NOS—Topiramate—obesity	0.00128	0.00128	CcSEcCtD
Tobramycin—Infestation—Topiramate—obesity	0.00128	0.00128	CcSEcCtD
Tobramycin—Decreased appetite—Sibutramine—obesity	0.00128	0.00128	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Sibutramine—obesity	0.00127	0.00127	CcSEcCtD
Tobramycin—Renal failure—Topiramate—obesity	0.00126	0.00126	CcSEcCtD
Tobramycin—Pain—Sibutramine—obesity	0.00126	0.00126	CcSEcCtD
Tobramycin—Nervous system disorder—Bupropion—obesity	0.00126	0.00126	CcSEcCtD
Tobramycin—Neuropathy peripheral—Topiramate—obesity	0.00126	0.00126	CcSEcCtD
Tobramycin—Thrombocytopenia—Bupropion—obesity	0.00126	0.00126	CcSEcCtD
Tobramycin—Feeling abnormal—Orlistat—obesity	0.00126	0.00126	CcSEcCtD
Tobramycin—Stomatitis—Topiramate—obesity	0.00125	0.00125	CcSEcCtD
Tobramycin—Skin disorder—Bupropion—obesity	0.00125	0.00125	CcSEcCtD
Tobramycin—Gastrointestinal pain—Orlistat—obesity	0.00125	0.00125	CcSEcCtD
Tobramycin—Anorexia—Bupropion—obesity	0.00123	0.00123	CcSEcCtD
Tobramycin—Feeling abnormal—Sibutramine—obesity	0.00122	0.00122	CcSEcCtD
Tobramycin—Epistaxis—Topiramate—obesity	0.00121	0.00121	CcSEcCtD
Tobramycin—Urticaria—Orlistat—obesity	0.00121	0.00121	CcSEcCtD
Tobramycin—Gastrointestinal pain—Sibutramine—obesity	0.00121	0.00121	CcSEcCtD
Tobramycin—Sinusitis—Topiramate—obesity	0.00121	0.00121	CcSEcCtD
Tobramycin—Body temperature increased—Orlistat—obesity	0.00121	0.00121	CcSEcCtD
Tobramycin—Abdominal pain—Orlistat—obesity	0.00121	0.00121	CcSEcCtD
Tobramycin—Agranulocytosis—Topiramate—obesity	0.0012	0.0012	CcSEcCtD
Tobramycin—Urticaria—Sibutramine—obesity	0.00117	0.00117	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Bupropion—obesity	0.00117	0.00117	CcSEcCtD
Tobramycin—Abdominal pain—Sibutramine—obesity	0.00117	0.00117	CcSEcCtD
Tobramycin—Body temperature increased—Sibutramine—obesity	0.00117	0.00117	CcSEcCtD
Tobramycin—Rhinitis—Topiramate—obesity	0.00116	0.00116	CcSEcCtD
Tobramycin—Paraesthesia—Bupropion—obesity	0.00115	0.00115	CcSEcCtD
Tobramycin—Dyspnoea—Bupropion—obesity	0.00115	0.00115	CcSEcCtD
Tobramycin—Pharyngitis—Topiramate—obesity	0.00114	0.00114	CcSEcCtD
Tobramycin—Urinary tract disorder—Topiramate—obesity	0.00114	0.00114	CcSEcCtD
Tobramycin—Connective tissue disorder—Topiramate—obesity	0.00113	0.00113	CcSEcCtD
Tobramycin—Urethral disorder—Topiramate—obesity	0.00113	0.00113	CcSEcCtD
Tobramycin—Hypersensitivity—Orlistat—obesity	0.00112	0.00112	CcSEcCtD
Tobramycin—Decreased appetite—Bupropion—obesity	0.00112	0.00112	CcSEcCtD
Tobramycin—Visual impairment—Topiramate—obesity	0.00111	0.00111	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Bupropion—obesity	0.00111	0.00111	CcSEcCtD
Tobramycin—Pain—Bupropion—obesity	0.0011	0.0011	CcSEcCtD
Tobramycin—Asthenia—Orlistat—obesity	0.00109	0.00109	CcSEcCtD
Tobramycin—Hypersensitivity—Sibutramine—obesity	0.00109	0.00109	CcSEcCtD
Tobramycin—Pruritus—Orlistat—obesity	0.00108	0.00108	CcSEcCtD
Tobramycin—Eye disorder—Topiramate—obesity	0.00108	0.00108	CcSEcCtD
Tobramycin—Tinnitus—Topiramate—obesity	0.00108	0.00108	CcSEcCtD
Tobramycin—Feeling abnormal—Bupropion—obesity	0.00106	0.00106	CcSEcCtD
Tobramycin—Asthenia—Sibutramine—obesity	0.00106	0.00106	CcSEcCtD
Tobramycin—Gastrointestinal pain—Bupropion—obesity	0.00105	0.00105	CcSEcCtD
Tobramycin—Angiopathy—Topiramate—obesity	0.00105	0.00105	CcSEcCtD
Tobramycin—Pruritus—Sibutramine—obesity	0.00104	0.00104	CcSEcCtD
Tobramycin—Diarrhoea—Orlistat—obesity	0.00104	0.00104	CcSEcCtD
Tobramycin—Immune system disorder—Topiramate—obesity	0.00104	0.00104	CcSEcCtD
Tobramycin—Mediastinal disorder—Topiramate—obesity	0.00104	0.00104	CcSEcCtD
Tobramycin—Urticaria—Bupropion—obesity	0.00102	0.00102	CcSEcCtD
Tobramycin—Body temperature increased—Bupropion—obesity	0.00102	0.00102	CcSEcCtD
Tobramycin—Abdominal pain—Bupropion—obesity	0.00102	0.00102	CcSEcCtD
Tobramycin—Diarrhoea—Sibutramine—obesity	0.00101	0.00101	CcSEcCtD
Tobramycin—Dizziness—Orlistat—obesity	0.00101	0.00101	CcSEcCtD
Tobramycin—Erythema—Topiramate—obesity	0.001	0.001	CcSEcCtD
Tobramycin—Dysgeusia—Topiramate—obesity	0.000983	0.000983	CcSEcCtD
Tobramycin—Dizziness—Sibutramine—obesity	0.000976	0.000976	CcSEcCtD
Tobramycin—Back pain—Topiramate—obesity	0.000971	0.000971	CcSEcCtD
Tobramycin—Vomiting—Orlistat—obesity	0.000969	0.000969	CcSEcCtD
Tobramycin—Rash—Orlistat—obesity	0.000961	0.000961	CcSEcCtD
Tobramycin—Dermatitis—Orlistat—obesity	0.00096	0.00096	CcSEcCtD
Tobramycin—Headache—Orlistat—obesity	0.000955	0.000955	CcSEcCtD
Tobramycin—Hypersensitivity—Bupropion—obesity	0.000948	0.000948	CcSEcCtD
Tobramycin—Vision blurred—Topiramate—obesity	0.000946	0.000946	CcSEcCtD
Tobramycin—Vomiting—Sibutramine—obesity	0.000938	0.000938	CcSEcCtD
Tobramycin—Ill-defined disorder—Topiramate—obesity	0.000932	0.000932	CcSEcCtD
Tobramycin—Rash—Sibutramine—obesity	0.00093	0.00093	CcSEcCtD
Tobramycin—Dermatitis—Sibutramine—obesity	0.000929	0.000929	CcSEcCtD
Tobramycin—Anaemia—Topiramate—obesity	0.000928	0.000928	CcSEcCtD
Tobramycin—Headache—Sibutramine—obesity	0.000924	0.000924	CcSEcCtD
Tobramycin—Asthenia—Bupropion—obesity	0.000923	0.000923	CcSEcCtD
Tobramycin—Pruritus—Bupropion—obesity	0.00091	0.00091	CcSEcCtD
Tobramycin—Nausea—Orlistat—obesity	0.000906	0.000906	CcSEcCtD
Tobramycin—Malaise—Topiramate—obesity	0.000905	0.000905	CcSEcCtD
Tobramycin—Vertigo—Topiramate—obesity	0.000902	0.000902	CcSEcCtD
Tobramycin—Leukopenia—Topiramate—obesity	0.000899	0.000899	CcSEcCtD
Tobramycin—Diarrhoea—Bupropion—obesity	0.00088	0.00088	CcSEcCtD
Tobramycin—Nausea—Sibutramine—obesity	0.000876	0.000876	CcSEcCtD
Tobramycin—Cough—Topiramate—obesity	0.000876	0.000876	CcSEcCtD
Tobramycin—Myalgia—Topiramate—obesity	0.000855	0.000855	CcSEcCtD
Tobramycin—Chest pain—Topiramate—obesity	0.000855	0.000855	CcSEcCtD
Tobramycin—Dizziness—Bupropion—obesity	0.000851	0.000851	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000849	0.000849	CcSEcCtD
Tobramycin—Discomfort—Topiramate—obesity	0.000845	0.000845	CcSEcCtD
Tobramycin—Confusional state—Topiramate—obesity	0.000826	0.000826	CcSEcCtD
Tobramycin—Vomiting—Bupropion—obesity	0.000818	0.000818	CcSEcCtD
Tobramycin—Rash—Bupropion—obesity	0.000811	0.000811	CcSEcCtD
Tobramycin—Dermatitis—Bupropion—obesity	0.00081	0.00081	CcSEcCtD
Tobramycin—Headache—Bupropion—obesity	0.000806	0.000806	CcSEcCtD
Tobramycin—Nervous system disorder—Topiramate—obesity	0.000804	0.000804	CcSEcCtD
Tobramycin—Thrombocytopenia—Topiramate—obesity	0.000802	0.000802	CcSEcCtD
Tobramycin—Skin disorder—Topiramate—obesity	0.000796	0.000796	CcSEcCtD
Tobramycin—Anorexia—Topiramate—obesity	0.000781	0.000781	CcSEcCtD
Tobramycin—Nausea—Bupropion—obesity	0.000764	0.000764	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Topiramate—obesity	0.000747	0.000747	CcSEcCtD
Tobramycin—Paraesthesia—Topiramate—obesity	0.000736	0.000736	CcSEcCtD
Tobramycin—Dyspnoea—Topiramate—obesity	0.000731	0.000731	CcSEcCtD
Tobramycin—Decreased appetite—Topiramate—obesity	0.000712	0.000712	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Topiramate—obesity	0.000707	0.000707	CcSEcCtD
Tobramycin—Pain—Topiramate—obesity	0.000701	0.000701	CcSEcCtD
Tobramycin—Feeling abnormal—Topiramate—obesity	0.000675	0.000675	CcSEcCtD
Tobramycin—Gastrointestinal pain—Topiramate—obesity	0.00067	0.00067	CcSEcCtD
Tobramycin—Urticaria—Topiramate—obesity	0.000651	0.000651	CcSEcCtD
Tobramycin—Abdominal pain—Topiramate—obesity	0.000648	0.000648	CcSEcCtD
Tobramycin—Body temperature increased—Topiramate—obesity	0.000648	0.000648	CcSEcCtD
Tobramycin—Hypersensitivity—Topiramate—obesity	0.000604	0.000604	CcSEcCtD
Tobramycin—Asthenia—Topiramate—obesity	0.000588	0.000588	CcSEcCtD
Tobramycin—Pruritus—Topiramate—obesity	0.00058	0.00058	CcSEcCtD
Tobramycin—Diarrhoea—Topiramate—obesity	0.000561	0.000561	CcSEcCtD
Tobramycin—Dizziness—Topiramate—obesity	0.000542	0.000542	CcSEcCtD
Tobramycin—Vomiting—Topiramate—obesity	0.000521	0.000521	CcSEcCtD
Tobramycin—Rash—Topiramate—obesity	0.000517	0.000517	CcSEcCtD
Tobramycin—Dermatitis—Topiramate—obesity	0.000516	0.000516	CcSEcCtD
Tobramycin—Headache—Topiramate—obesity	0.000513	0.000513	CcSEcCtD
Tobramycin—Nausea—Topiramate—obesity	0.000487	0.000487	CcSEcCtD
